• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Actuate Therapeutics, Inc. - Common stock (NQ:ACTU)

    2.640 +0.330 (+14.29%)
    Streaming Delayed Price Updated: 2:49 PM EDT, Apr 20, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 936,714
    Open 2.490
    Bid (Size) 2.600 (200)
    Ask (Size) 2.680 (800)
    Prev. Close 2.310
    Today's Range 2.400 - 3.100
    52wk Range 1.580 - 11.99
    Shares Outstanding 23,243,328
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Actuate Therapeutics: Poised for Potential $200M+ Pediatric Priority Review Vouchers and Transformative Combinations in RAS-Driven Cancers
    Via ACCESS Newswire
    News headline image
    Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer ↗
    Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026. 
    Via Stocktwits

    Performance

    YTD
    -56.2%
    -56.2%
    1 Month
    +12.3%
    +12.3%
    3 Month
    -52.5%
    -52.5%
    6 Month
    -64.3%
    -64.3%
    1 Year
    -68.5%
    -68.5%

    More News

    Read More
    News headline image
    12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday ↗
    Via Benzinga
    News headline image
    Actuate Therapeutics Advances a New Era in Oncology with Potential Universal Backbone Therapy
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Pheton, Powell Max Make Public Debut ↗
    Via Talk Markets
    News headline image
    Actuate Therapeutics Makes Public Debut ↗
    Via Talk Markets
    InvestorNewsBreaks – Actuate Therapeutics, Inc. (NASDAQ: ACTU) Closes on $22.4M Initial Public Offering
    Via Investor Brand Network

    Frequently Asked Questions

    Is Actuate Therapeutics, Inc. - Common stock publicly traded?
    Yes, Actuate Therapeutics, Inc. - Common stock is publicly traded.
    What exchange does Actuate Therapeutics, Inc. - Common stock trade on?
    Actuate Therapeutics, Inc. - Common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Actuate Therapeutics, Inc. - Common stock?
    The ticker symbol for Actuate Therapeutics, Inc. - Common stock is ACTU on the Nasdaq Stock Market
    What is the current price of Actuate Therapeutics, Inc. - Common stock?
    The current price of Actuate Therapeutics, Inc. - Common stock is 2.640
    When was Actuate Therapeutics, Inc. - Common stock last traded?
    The last trade of Actuate Therapeutics, Inc. - Common stock was at 04/20/26 02:49 PM ET
    What is the market capitalization of Actuate Therapeutics, Inc. - Common stock?
    The market capitalization of Actuate Therapeutics, Inc. - Common stock is 61.36M
    How many shares of Actuate Therapeutics, Inc. - Common stock are outstanding?
    Actuate Therapeutics, Inc. - Common stock has 61M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.